Annette D. Burden
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.
Journal: Clinical and translational science
Published: February 18, 2026
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares.
Journal: The Journal of clinical investigation
Published: July 01, 2025
Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking on palmoplantar pustulosis.
Journal: The British journal of dermatology
Published: April 16, 2025
Navigating Research Challenges to Estimate Blue Carbon Benefits From Saltmarsh Restoration.
Journal: Global change biology
Published: August 29, 2024
Response to: Letter to Editor Regarding "Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study".
Journal: Dermatology and therapy
Published: February 20, 2024
A genome-wide meta-analysis of palmoplantar pustulosis implicates TH2 responses and cigarette smoking in disease pathogenesis.
Journal: The Journal of allergy and clinical immunology
Published: January 24, 2024
Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy-Fatigue and pain-Visual Analogue Scale in patients with generalized pustular psoriasis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 30, 2023
Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1.
Journal: The Journal of investigative dermatology
Published: November 07, 2023
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update.
Journal: The British journal of dermatology
Published: August 18, 2023
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study.
Journal: Dermatology and therapy
Published: June 23, 2023
Global dataset of soil organic carbon in tidal marshes.
Journal: Scientific data
Published: June 14, 2023
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: May 23, 2023
Last Updated: 09/26/2026